Clinical Trial

Survey to Test the Nicotine Concentration and Nicotine Flux Labels for E-cigarettes

Not Yet Recruiting

Summary

Current labels for the nicotine in e-cigarette/vaping products do not sufficiently convey information to the public. The aims of this study include developing and validating two new types of labels for the nicotine in vaping products: nicotine concentration and nicotine flux (reflecting nicotine emissions). Investigators will survey youth (ages 14-20) and adults (ages 21+ \[21 is the legal age to purchase tobacco products in the U.S.\]) to evaluate the utility of several new labels investigators have developed.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2026-04-20; most recent amendment 2026-05-18.

Trial Details

NCT Number	NCT07553585
Lead Sponsor	Yale University Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Nicotine Labeling for E-cigarettes
Enrollment	2,500 participants
Start Date	2026-06-01
Primary Completion	2026-12-15 (estimated)
Study Completion	2026-12-15 (estimated)
Updated on ClinicalTrials.gov	2026-05-22